Wow ...bedwetters left and right
This is a clinical stage start up spending coin to get combinant synergistic drug candidates into commercial return, addressing unmet need globally, once they have passed regulatory certification....i.e they are not approved for human consumption or use.
I was privy to this???
he said she said that ???
SIG is all we have ??
paraphrasing thread sentiment here....
look at the company pipeline and the assets being developed
look at the market and decide your entry point
understanding markets are playgrounds to make money - not to demonstrate how fantastic a company is by a declining or increasing SP....asks and bids determine that alone irrespective of the company
there is no bottom in a market for that reason and all SP positions are influenced the same way ....everyone bitches about short contracts wtf ?
its a market - that's how they work
Incannex will appreciate value
when significant human data drops on the assets being driven to
approval and commercialisation - and revenue is the second carrot driver of SP appreciation for disruptive start upsIf you don't believe through understanding the drugs and the management team in the assets and the company achieving regulatory approval in the disruptive healthcare space you are lost in the red - and you will not see quality SP appreciation till the HUMAN data hits the table.....
its that simple
if you dropped money in here for some other reason you will have to wait - you can gaze the SP every second of every hour and blame everyone one you like .....HUMAN data will be the driver followed by revenue
there is no bottom - its a market!....a 600 billion dollar market into 2025 - there is no comparison to the ASX...zero....nada -
if they fail they fail
should they win they win big!
that's the risk reward -
red or black....its
your chip / you decide - don't bleat if you now think you are wrong......you are your own advisor ALWAYS
good luck to us all
